Blog

Yttrium-90 or Y90is a commonly used isotope in the medical field specially in departments like nuclear medicine and radiation oncology for radiation therapy. This radioisotope is relied upon

Transarterial Chemoembolisation or TACE has been the initial treatment modality for HCC and has a huge body of evidence from several studies and clinical trials. Therefore, for long TACE has

This overview provides the patient and the caregiver a peek at what to expect during a typical PRRT treatment with Lu177 (Lutathera) and it covers the following aspects of a typical PRRT tre

The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent that 'sees' the lesion and the other, a co

The question that most patients and caregivers ask – What is Targeted Alpha Therapy or Alpha PSMA Therapy? Targeted Alpha PSMA Therapy is a targeted, selective internal cellular level radi

The Nuclear Medicine Therapy Centre at Fortis Memorial Research Institute (FMRI) is the Only Centre in India Offering Myeloblative MIBG Therapy for High Risk Neuroblastomas in Children.

TARE is a palliative treatment (it means that it does not provide a cure) that helps slow down the disease growth and also helps alleviate symptoms. It is often used as a treatment option fo

PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a small amount of radioactive material that

PRRT is a short form for Peptide Receptor Radionuclide Therapy. It is also known as molecular therapy or radioisotope therapy. PRRT has been found to be very effective in the treatment on ce

Oligometastatic prostate cancer (OMPC) that has five or fewer sites of metastasis is considered a transitional state between localized and widespread metastatic tumors. With improvements in

Neuroendocrine tumours (NETs) are heterogeneous with varying behaviour. Treatment decisions are taken basis Histological studies plus imaging data and clinical studies. Surgery is a curative

My last article (Which patients can benefit with PPRT?) summed up the fundamentals of Nuclear Medicine PRRT and which patients may benefit from this therapy. Today, I shall be giving you a l

In the past one year, the Nuclear Oncology Experts team at the Department of Nuclear Medicine at Fortis Memorial Research Institute has treated 30 new patients of Castrate Resistant Prostate

I am writing this blog to guide patients who would want to come to India for medical treatment. This is a step-by-step logistics guide and is entirely based on my experience and what steps I

I am a Prostate Cancer patient from USA (name withheld on request). I came to India, specifically to the Department of Nuclear Medicine & Molecular Imaging at Fortis Memorial Research Instit

For prostate cancer patients who have become refractory to conventional therapy, the department of Nuclear Medicine & Molecular Imaging at the Fortis Memorial Research Institute (FMRI) in In

For advanced prostate cancer patients or metastatic castration-resistant prostate cancer (mCRPC) patients, conventional treatment modalities, such as surgery, chemotherapy etc. might not pro

Cancer is an abnormal cellular growth in a specific body region that is able to spread internally and cover other areas. If left untreated, it causes a number of life-threatening conditions

Before we go on to discuss the above topic at hand, let me explain PRRT. In PRRT, a radiopeptide is created by combining a small amount of radioactive material or radionuclide (Yttrium-90 or